[ET Net News Agency, 29 October 2026] HANSOH PHARMA (03692) rose 3% to HK$33.12.
It hits an intra-day high of HK$33.22, breaking above the 100-D SMA of HK$32.42, and an intra-day low of HK$32.36. The total shares traded was 5.3 million, with a value of HK$173.58m. The active buy/sell ratio is 68:32, with net buying turnover of HK$59.36m. GOLDMAN SACHS (ASIA) SEC accounts for greatest net responsive buying turnover of HK$1.25m, with volume weighted average price of HK$32.803. ABN AMRO CLEARING HK accounts for greatest net responsive selling turnover of HK$18.63m, with volume weighted average price of HK$32.796. The stock has risen a combined 4% over the past 2 consecutive trading days.
The Hang Seng Index now rose 28 points, or 0.1% to 23,123; the Hang Seng China Enterprises Index now rose 25 points, or 0.3% to 7,816.
Basic Information| Nominal | 33.120 | % Chg | +3.05% |
| High | 33.220 | Low | 32.360 |
| Shares Tr | 5.3m | Turnover | 173.58m |
| 10-D SMA | 32.684 | %H.V | 55.785 |
| 20-D SMA | 32.811 | VWAP | 32.780 |
| 50-D SMA | 33.568 | RSI14 | 50.783 |
Status: Breaking above the 100-D SMA, active buy/sell ratio is 68:32, with net buying turnover of HK$59.36m, rising a combined 4% over the past 2 consecutive trading days
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| HANSOH PHARMA (03692) | 33.120 | +3.05 |
| SIHUAN PHARM (00460) | 0.715 | -1.38 |
| GRAND PHARMA (00512) | 4.370 | +0.58 |
| SBP GROUP (01177) | 4.900 | +0.93 |
| HENGRUI PHARMA (01276) | 50.850 | +2.60 |
| LIVZON PHARMA (01513) | 22.100 | +0.09 |
| LUYE PHARMA (02186) | 1.590 | -0.93 |
| FOSUN PHARMA (02196) | 16.210 | -2.05 |
| SH PHARMA (02607) | 11.000 | -0.45 |
| CHINARES PHARMA (03320) | 4.470 | -1.76 |
(ed)
Nominal 
